Authors:
Myhr, KM
Riise, T
Vedeler, C
Nortvedt, MW
Gronning, M
Midgard, R
Nyland, HI
Citation: Km. Myhr et al., Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension, MULT SCLER, 7(1), 2001, pp. 59-65
Authors:
Willison, HJ
Ang, W
Gilhus, NE
Graus, F
Liblau, R
Vedeler, C
Vincent, A
Citation: Hj. Willison et al., EFNS Task Force Report: a questionnaire-based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres, EUR J NEUR, 7(6), 2000, pp. 625-628
Authors:
Romi, F
Skeie, GO
Vedeler, C
Aarli, JA
Zorzato, F
Gilhus, NE
Citation: F. Romi et al., Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis - A study of IgG subclasses and clinical correlations, J NEUROIMM, 111(1-2), 2000, pp. 169-176
Citation: Km. Myhr et al., Immunoglobulin G Fc-receptor (Fc gamma R) IIA and IIIB polymorphisms related to disability in MS, NEUROLOGY, 52(9), 1999, pp. 1771-1776
Authors:
Myhr, KM
Riise, T
Lilleas, FEG
Beiske, TG
Celius, EG
Edland, A
Jensen, D
Larsen, JP
Nilsen, R
Nortvedt, MW
Smievoll, AI
Vedeler, C
Nyland, HI
Citation: Km. Myhr et al., Interferon-alpha 2a reduces MRI disease activity in relapsing-remitting multiple sclerosis, NEUROLOGY, 52(5), 1999, pp. 1049-1056
Citation: H. Flaatten et al., Post-dural puncture related complications after diagnostic lumbar puncture, myelography and spinal anaesthesia, ACT NEUR SC, 98(6), 1998, pp. 445-451